PAULA WHITTLE: Open Payments
NPI 1265794002 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$181 in 4 payments from 4 companies in 2025. Trend: 2023 $228 · 2024 $949 · 2025 $181
Food & beverage: $181
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: QULIPTA, SPRAVATO, Auvelity, CAPLYTA.
Industry payments across NE — which companies pay providers there.
